Market and pricing volatility arising from legal regulations affecting the pharmaceutical and medical industries
First written in FY2018. 2 of 3 entries say "Restated". Latest entry: FY2021.
The whole theme swung hardest in 2018: 21 of 66 companies on the "Worse" side.
47 other companies' latest entry also says "Restated".
- FY2021RestatedAnnual report
「Some customers operate in industries subject to legal regulations, such as pharmaceuticals and medical equipment.」
The Company continues to describe how legal regulations affecting the pharmaceutical, medical equipment and other industries affect the business environment. - FY2020RestatedAnnual report
「The Group comprises 3 businesses: the Packaging Plant Business, Mechatronics Systems Business and Agricultural Equipment Business. All businesses are affected by trends in customers’ capital investment. Some customers operate in industries subject to legal regulations, such as pharmaceuticals and medical equipment.」
The Company continues to describe how legal regulations affecting the pharmaceutical, medical equipment and other industries affect the business environment. - FY2018First statedAnnual report
「The Group manufactures and sells packaging system products to the pharmaceutical industry and manufactures, sells and supplies medical equipment on an OEM basis. These industries are subject to healthcare insurance administration regulations, which appear to affect the market and prices of the Group’s products both directly and indirectly. If future administrative developments cause the market to contract or prices to fall, business performance could be adversely affected.」
The Company states that regulations governing healthcare insurance administration in the pharmaceutical and medical industries could lead to market contraction or price declines.